SynerFuse progresses with spinal fusion, neuromodulation implantation study

Carly Behm -  

Michael Park, MD, PhD, and Rohan Lall, MD, completed the fifth procedure using SynerFuse's spine implant as part of a proof-of-concept study combining spinal fusion with the implant of a neurostimulator.

The fifth case is a key milestone in the study because a data safety monitoring board will be able to review the SynerFuse concept, according to a July 26 news release. 

"We're one step closer to demonstrating the viability of our non-narcotic solution for spinal fusion patients with chronic lower back pain," SynerFuse CEO Justin Zenanko said in the release.

The combination procedure adds a neurostimulator to stimulate the dorsal root ganglion to provide relief to patients with back pain. The study will enroll up to 20 patients, the release said.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Learning Opportunities

Featured Webinars

Featured Podcast

Featured Whitepapers